Oncology Biosimilars Market Scope And Analysis

  • Report Code : TIPRE00002766
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Oncology Biosimilars Market Analysis and Scope 2021-2031

Buy Now

Oncology Biosimilars Market Report Oncology Biosimilars Market Size and Share Oncology Biosimilars Market Scope and Analysis

Oncology Biosimilars Market Report Scope

Report Attribute Details
Market size in 2023 US$ 9.46 Billion
Market Size by 2031 US$ 24.71 Billion
Global CAGR (2023 - 2031) 12.8%
Historical Data 2021-2023
Forecast period 2023-2031
Segments Covered By Drug Class
  • Monoclonal Antibodies
  • Granulocyte Colony-Stimulating Factor
  • Erythropoiesis-Stimulating Agents
By Cancer Type
  • Colorectal Cancer
  • Cervical Cancer
  • Breast Cancer
  • Supportive Care
  • Lymphoma
By and Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • CELLTRION Inc
  • Teva Pharmaceutical Industries Ltd
  • Pfizer Inc
  • Sandoz Group AG
  • Biocon
  • Amgen Inc
  • Samsung Bioepis
  • Coherus BioSciences
  • BIOCAD